SCHEMBL13383448

SCHEMBL13383448

C1=CC2(CCC1)CCCCNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11007598 0.94 HTR2A (0.31)
SCHEMBL13383443 0.92
SCHEMBL8122730 0.90 ALDH1A1 (0.31)
SCHEMBL23330053 0.89
SCHEMBL5432009 0.88
SCHEMBL5783631 0.85 HTR2A (0.31)
SCHEMBL29297608 0.82
SCHEMBL5429965 0.81 HTR2A (0.31)
SCHEMBL13383447 0.77
SCHEMBL11073756 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691844-B2 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2010-04-06 US disclosed
US-7365062-B2 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2008-04-29 US disclosed
US-20070135409-A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists ORTHO-MCNEIL PHARMACEUTICAL, INC. 2007-06-14 US disclosed
US-20070117790-A1 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure ORTHO MCNEIL PHARMACEUTICAL, INC. 2007-05-24 US disclosed